THE GLOBAL RESPONSE TO HIV

THE GLOBAL RESPONSE TO HIV:   90-90-90 by 2020 – what does it mean and will we make it?

In 2013, UNAIDS set the ambitious target of 90-90-90 by 2020.

  • By 2020, 90% of all people living with HIV will know their HIV status
  • By 2020, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy
  • By 2020, 90% of all people receiving antiretroviral therapy will have viral suppression

While predominantly a treatment target, this is underpinned by the other elements of an appropriate and sustainable response, i.e. the need to scale-up other core prevention strategies such as elimination of mother-to-child transmission, pre exposure prophylaxis (PrEP), condom programming, voluntary medical male circumcision in priority countries, harm reduction services for people who inject drugs, and focused prevention programmes for other key populations. Concerted efforts will also be needed to eliminate the stigma, discrimination and social exclusion.

Living with HIV is the first in a five part Living with... series created in partnership with ICON. This panel discussion, moderated by broadcaster Ciara Kelly will examine the varied experiences of patients, clinicians, and researchers who are all challenging the perception of what it means to live beyond a diagnoses and thrive with a chronic health condition.  The event runs from 6pm-7pm and will be live streamed on Facebook

PANEL

Thomas Strong, Member of Act UP and lecturer in anthropology at Maynooth University:  Thomas has been living with HIV since 2006.  In 2016, he wrote an opinion piece for the Irish Times entitled, “How can there be such thing as guilty or innocent HIV?”  

Adam Shanley, MSM Programme Manager with HIV Ireland: Gay, bisexual and other men who have sex with men (MSM) are disproportionately affected by HIV and STIs in Ireland. Adam's role aims to respond to the sexual health and wellbeing needs of this community by developing innovative interventions and services. HIV Ireland is a non-profit organisation whose mission is to contribute towards a significant reduction in the incidence and prevalence of HIV in Ireland and towards the realisation of an AIDS-free generation.

Caroline Forkin, Senior Director of Medical Affairs in ICON: Caroline has twenty four years’ experience as a physician, including nine years in Mozambique working for the World Bank and Irish Aid in International Health, primarily as an advisor in the area of HIV and AIDS. Since returning to Ireland, she has worked in the biotech pharmaceutical industry with Shire Pharmaceuticals and Amgen Pharmaceuticals before joining ICON in her current role. She holds a Membership of the Royal College of Physicians of Ireland (MRCPI), an MBA in Healthcare Management, and holds Diplomas in Public Health and Pharmaceutical Medicine.

Dr Nigel Stevenson, Assistant Professor Immunology at Trinity College Dublin: Professor Stevenson's research at Trinity analyses the effect of viruses upon the immune system. He has recently published a new mechanism by which HIV blocks responses to innate immunity, which is a major breakthrough in HIV research. 

Ciara Kelly, Broadcaster and Panel Moderator: Ciara Kelly is a journalist and broadcaster on Irish radio. She is the presenter of 'Lunchtime Live' on Newstalk. She also has a weekly column with the Irish Independent.

 

About Science Gallery Dublin

Established in 2008 by Trinity College Dublin, Science Gallery Dublin’s mission is to engage 15-25 year olds through the intersections of art and science. Since its opening, more than three million visitors to the nonprofit gallery have experienced 45 unique exhibitions, ranging from design and violence to light and love, and from contagion and biomimicry to the futures of the human species and play. At the heart of Science Gallery Dublin lies a rich network of collaborators: artists, designers, performers, academics, scientists, researchers and extraordinary colleagues located in Science Gallery nodes across the world.

 

About ICON

ICON is a global provider of drug development solutions and services to pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. Founded and headquartered in Dublin since 1990, ICON currently, operates from 90 locations in 37 countries and has approximately 13,680 employees.

  • Date: 
  • Time: 
  • Where: Paccar Theatre
  • Price: FREE
  • Register Now

What’s On